3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
2
Recruiting
2
Terminated
1
Not yet recruiting
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Prostatic Neoplasms
36
Lymphoma, Large B-Cell, Diffuse
16
Lymphoma
16
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Burkitt Lymphoma
7
Neoplasms
6
Multiple Myeloma
6
Lymphoma, Non-Hodgkin
6
Lymphoma, Follicular
6
Leukemia
6
Lymphoma, B-Cell
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Recurrence
3
Neoplasm Metastasis
3
Lymphoma, T-Cell
3
Lymphoma, B-Cell, Marginal Zone
3
Hodgkin Disease
3
Waldenstrom Macroglobulinemia
2
Pain
2
Neoplasms by Histologic Type
2
Myelodysplastic Syndromes
2
Lymphatic Diseases
2
Immunoproliferative Disorders
2
Immune System Diseases
2
Hematologic Neoplasms
2
Hematologic Diseases
2
Urologic Neoplasms
1
Triple Negative Breast Neoplasms
1
Solid Tumours
1
Sezary Syndrome
1
Interventions
thymoglobulin
1
satralizumab
1
rhoA GTP-Binding Protein
1
eculizumab
1
Sugars
1
Steroids
1
Prednisone
1
Methylprednisolone
1
Mesna
1
Immunoglobulins
1
Hizentra
1
Hematopoietic Stem Cell Transplantation
1
Granulocyte Colony-Stimulating Factor
1
Cyclophosphamide
1
CK-2017357
1
Bortezomib
1
Amifampridine
1
Abatacept
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Myasthenia Gravis
×
Prednisone
×
Clear all
NCT00995722
2017-06-02
EPITOME'
University of Miami
Phase 3
Terminated
11 enrolled
14 charts